Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

IND. 192 -- Phase II Study of Deforolimus in Patients with Metastatic and/or Locally Advanced Recurrent Endometrial Cancer -- was centrally activated 26 August 2008.
http://www.ctg.queensu.ca/trials/ind/i192/192.html